NanoDimension is a venture capital firm investing in disruptive technologies in and at the convergence of the life and physical sciences.
Business Model:
Revenue: $0
Employees: 0-0
Address:
City:
State:
Zip:
Country:
NanoDimension is a leading venture capital firm investing in disruptive technologies in and at the convergence of the life and physical sciences. We focus on early stage opportunities in the US and Europe led by exceptional entrepreneurs. NanoDimension’s investment team takes an active approach to building portfolio companies, leveraging our expertise and network to find and build companies with innovative solutions to critical global problems.
Contact Phone:
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|---|---|---|
12/2019 | Arctos Medical | Seed Round | 0 |
10/2019 | Icosavax | Series A | 0 |
1/2010 | SBA Materials | Venture Round | 5.2M |
6/2015 | Twist Bioscience | Series C | 37M |
3/2008 | Xtellus | Venture Round | 8.3M |
8/2017 | ARMO BioSciences | Series C | 0 |
2/2016 | ARMO BioSciences | Series C | 50M |
10/2016 | Emulate | Series B | 0 |
11/2007 | BIND Therapeutics | Series B | 16M |
7/2020 | Natron Energy | Series D | 0 |
2/2018 | H55 | Venture Round | - |
7/2013 | Crocus Technology | Series D | 0 |
6/2012 | View | Series D | 0 |
1/2016 | Pulse Therapeutics | Venture Round | 10M |
7/2014 | Emulate | Series A | 12M |
5/2010 | Crocus Technology | Series C | 0 |
4/2019 | Inscripta | Series C | 0 |
4/2010 | Selecta Biosciences | Series C | 15M |
2/2017 | Inscripta | Series B | 23M |
1/2015 | Tarveda Therapeutics | Series B | 21M |
1/2016 | Twist Bioscience | Series D | 61M |
11/2013 | View | Venture Round | 12.6M |
1/2012 | Tarveda Therapeutics | Series A | 2.8M |
10/2008 | Crocus Technology | Series B | 15.9M |
5/2014 | ARMO BioSciences | Series B | 30M |
7/2018 | Serotiny | Seed Round | 3M |
9/2019 | Amphivena Therapeutics | Series C | 0 |
6/2015 | Crocus Technology | Series E | 21M |
12/2013 | Tarveda Therapeutics | Series B | 21M |
9/2015 | Selecta Biosciences | Series E | 38M |
10/2014 | Selecta Biosciences | Private Equity Round | 20M |
9/2016 | SQZ Biotech | Series B | 16M |
4/2021 | Icosavax | Series B | 0 |
6/2010 | BIND Therapeutics | Series C | 12.4M |
5/2020 | SQZ Biotech | Series D | 0 |
2/2009 | Selecta Biosciences | Series B | 15.1M |
12/2010 | View | Series C | 40M |
2/2017 | Tarveda Therapeutics | Series D | 30M |
2/2018 | Inscripta | Series C | 55.5M |
5/2014 | Twist Bioscience | Series B | 26M |
12/2018 | Inscripta | Series C | 0 |
8/2018 | SQZ Biotech | Series C | 0 |
4/2021 | Icosavax | Series B | 0 |
7/2020 | Natron Energy | Series D | 0 |
5/2020 | SQZ Biotech | Series D | 0 |
12/2019 | Arctos Medical | Seed Round | 0 |
10/2019 | Icosavax | Series A | 0 |
9/2019 | Amphivena Therapeutics | Series C | 0 |
4/2019 | Inscripta | Series C | 0 |
12/2018 | Inscripta | Series C | 0 |
8/2018 | SQZ Biotech | Series C | 0 |
7/2018 | Serotiny | Seed Round | 0 |
Name | Price |
---|
Name | Size | Announced Date |
---|